Cellex
VerifiedHighly innovative company in the biomedical sector, focused on research.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$4—5m (Dealroom.co estimates Jan 2024.)
Rome Lazio (HQ)
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | - | 14 % | 12 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | (628 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | - | (1162 %) | - | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
* | €830k | Seed | |
| Total Funding | 000k | ||
Related Content
Recent News about Cellex
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.